Industry stakeholders and grassroots advocates in DME and CRT have cleared one hurdle working towards relief for suppliers across the country, but there is still work to be done moving into the final days of the 114th Congress. Outlets are reporting that the Senate will be holding a vote on H.R. 34, which is the vehicle for the Cures Act that passed overwhelmingly in the House Wednesday evening.
H.R. 34 passed 392-26 which was a great indication of support in what could have been a potentially vulnerable bill in the days before. Now, the legislation heads to the Senate where a vote is expected on Monday evening. Having such a huge margin voting for this legislation in what has been a rather divided House puts pressure on the Senate to get the bill passed and sent to the president’s desk. There has been slight push-back from a few senators of both sides of the isle because of certain provisions in the 996-page bill, none of which have indicated being against DME or CRT.
Senators Elizabeth Warren (D-Mass) and Bernie Sanders (I-Vt.) have been openly against the legislation citing “numerous corporate giveaways” to drug companies. Just as a couple of Republicans had shown a degree of concern about certain provisions, some of which were removed before passage in the House. Knowing there is some uneasiness in the Senate because of objections that some senators have, it is crucial to ensure they are reminded of the many positive things this legislation does, especially for DME and CRT providers.
What can providers do?
Please reach out to your Senators today and tomorrow urging them to support the Cures Act in order to preserve access to vital medical equipment for Medicare beneficiaries!
Call the U.S. Capitol switchboard at – (202) 224-3121 to be directed to your senator’s office.